Restructuring likely to sweep pharmaceutical industry

The accelerating downturn in consumer confidence due to a deadly cocktail of recession fears and subsequent plunge of asset values is making it harder for pharmaceutical companies to do business.

Analysts expect restructuring seems inevitable to offset worsening profitability in the midst of cost hike in raw material materials and the Korean won’s value plunge.

To counter rough times, a ...